Company Filing History:
Years Active: 2014-2019
Title: Andrea Pierleoni: Innovator in Oncology
Introduction
Andrea Pierleoni is a distinguished inventor based in Siena, Italy. With a focus on oncology, he has significantly contributed to the field through his innovative patents. Pierleoni's work revolves around the development of diagnostic tools and therapeutic strategies to improve cancer detection and treatment.
Latest Patents
Andrea Pierleoni holds three patents, with his latest inventions focusing on tumor markers and their applications. One of his notable patents, "Ovary tumor markers and methods of use thereof," introduces newly identified proteins that serve as markers for the detection of ovarian tumors. The invention also encompasses affinity ligands that selectively interact with these proteins, offering potential therapeutic targets for treatment. Another patent, "Tumor markers and methods of use thereof," provides similar innovations for detecting tumors, particularly in lung, colon, breast, and ovarian cancers. This patent includes methods for screening tissue samples for malignancy and determining the presence of tumors, as well as a diagnostic kit for screening test compounds as potential antitumor candidates.
Career Highlights
Andrea Pierleoni is currently associated with Externautics S.p.a., where he has been instrumental in advancing the company's research initiatives. His expertise in oncology and diagnostics plays a pivotal role in shaping innovative solutions for cancer treatment and monitoring.
Collaborations
Throughout his career, Pierleoni has collaborated with notable colleagues, including Renata Grifantini and Piero Pileri. These partnerships have fostered a collaborative research environment that amplifies the impact of their discoveries in the healthcare sector.
Conclusion
Andrea Pierleoni exemplifies the innovative spirit in the field of oncology, with a strong focus on developing diagnostic and therapeutic strategies for cancer detection and treatment. His contributions through multiple patents underline the importance of innovation in enhancing patient care and outcomes in oncology.